We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Study of Rasagiline in Parkinson's Disease Patients Using Levodopa

- Parkinson's Disease
- Completed

Study Title: Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

Teva Identifier: TV-1012/133

ClinicalTrials.gov Identifier: NCT00203034

Study Status: Completed

Trial Condition(s): Parkinson's Disease

Interventions: Drug: rasagiline mesylate | Drug: 1.0 mg rasagiline mesylate | Other: Placebo

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

neurology icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 30 Years and older

Trial Duration: 05/01/2000 - 01/01/2003

Phase: Phase 3

Study Type

Interventional